SUSANNE ROMAN: Open Payments
NPI 1578211835 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,159 in 49 payments from 13 companies in 2025. Trend: 2023 $559 · 2024 $1,105 · 2025 $1,159
Food & beverage: $1,159
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 13 | $282 |
| AstraZeneca Pharmaceuticals LP | 8 | $261 |
| Novartis Pharmaceuticals Corporation | 6 | $116 |
| Medicure Pharma Inc. | 1 | $100 |
| E.R. Squibb & Sons, L.L.C. | 5 | $96 |
| Philips North America LLC | 3 | $72 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
| Merck Sharp & Dohme LLC | 2 | $38 |
| AltaThera Pharmaceuticals LLC | 1 | $30 |
Products named: ELIQUIS, FARXIGA, LEQVIO, Zypitamag, Ambulatory Monitoring & Diagnostics Undivided, CAMZYOS, LifeVest, VYNDAQEL.
Industry payments across AL — which companies pay providers there.
